U.S. flag

An official website of the United States government

NM_001354604.2(MITF):c.355-1062G>C AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 29, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002534250.1

Allele description

NM_001354604.2(MITF):c.355-1062G>C

Gene:
MITF:melanocyte inducing transcription factor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p13
Genomic location:
Preferred name:
NM_001354604.2(MITF):c.355-1062G>C
HGVS:
  • NC_000003.12:g.69936760G>C
  • NG_011631.1:g.202279G>C
  • NG_050802.1:g.2463G>C
  • NM_000248.4:c.33+5G>C
  • NM_001184967.2:c.199-1062G>C
  • NM_001184968.2:c.33+5G>C
  • NM_001354604.2:c.355-1062G>CMANE SELECT
  • NM_001354605.2:c.352-1062G>C
  • NM_001354606.2:c.352-1062G>C
  • NM_001354607.2:c.304-1062G>C
  • NM_001354608.2:c.199-1062G>C
  • NM_006722.3:c.352-1062G>C
  • NM_198158.3:c.33+5G>C
  • NM_198159.3:c.355-1062G>C
  • NM_198177.3:c.307-1062G>C
  • NM_198178.3:c.33+5G>C
  • LRG_776t1:c.33+5G>C
  • LRG_776:g.202279G>C
  • NC_000003.11:g.69985911G>C
  • NM_000248.3:c.33+5G>C
Links:
dbSNP: rs1236436555
NCBI 1000 Genomes Browser:
rs1236436555
Molecular consequence:
  • NM_000248.4:c.33+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001184967.2:c.199-1062G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001184968.2:c.33+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354604.2:c.355-1062G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354605.2:c.352-1062G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354606.2:c.352-1062G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354607.2:c.304-1062G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001354608.2:c.199-1062G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_006722.3:c.352-1062G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_198158.3:c.33+5G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_198159.3:c.355-1062G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_198177.3:c.307-1062G>C - intron variant - [Sequence Ontology: SO:0001627]
  • NM_198178.3:c.33+5G>C - intron variant - [Sequence Ontology: SO:0001627]
Functional consequence:
effect on RNA splicing [Variation Ontology: 0362]

Condition(s)

Name:
Tietz syndrome (TADS)
Synonyms:
Albinism-deafness of Tietz; Hypopigmentation/deafness of Tietz; Tietz albinism-deafness syndrome
Identifiers:
MONDO: MONDO:0007077; MedGen: C0391816; Orphanet: 42665; OMIM: 103500
Name:
Waardenburg syndrome type 2A (WS2A)
Synonyms:
WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM
Identifiers:
MONDO: MONDO:0008671; MedGen: C1860339; Orphanet: 3440; OMIM: 193510
Name:
Melanoma, cutaneous malignant, susceptibility to, 8
Synonyms:
MELANOMA AND RENAL CELL CARCINOMA, SUSCEPTIBILITY TO; Cutaneous malignant melanoma 8
Identifiers:
MONDO: MONDO:0013759; MedGen: C3152204; Orphanet: 293822; OMIM: 614456

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003525336Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(May 29, 2022)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Molecular Study of Three Lebanese and Syrian Patients with Waardenburg Syndrome and Report of Novel Mutations in the EDNRB and MITF Genes.

Haddad NM, Ente D, Chouery E, Jalkh N, Mehawej C, Khoueir Z, Pingault V, Mégarbané A.

Mol Syndromol. 2011 Jan;1(4):169-175. Epub 2011 Jan 10.

PubMed [citation]
PMID:
21373256
PMCID:
PMC3042120

Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.

Buratti E, Chivers M, Královicová J, Romano M, Baralle M, Krainer AR, Vorechovsky I.

Nucleic Acids Res. 2007;35(13):4250-63. Epub 2007 Jun 18.

PubMed [citation]
PMID:
17576681
PMCID:
PMC1934990
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV003525336.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change falls in intron 1 of the MITF gene. It does not directly change the encoded amino acid sequence of the MITF protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (no rsID available, gnomAD no frequency). This variant has been observed in individuals with clinical features of autosomal dominant Waardenburg Syndrome, type 2A (PMID: 21373256, 30117279). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 545639). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant is associated with altered splicing resulting in multiple RNA products (PMID: 30117279). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 1, 2023